XML 30 R18.htm IDEA: XBRL DOCUMENT v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Daniel Faga [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On April 11, 2025, Daniel Faga, chief executive officer of the company, entered into a written plan for the potential sale of common stock. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. No shares were sold under the plan and it was subsequently terminated on July 15, 2025.
Name Daniel Faga
Title chief executive officer of the company
Rule 10b5-1 Arrangement Adopted true
Adoption Date April 11, 2025
Expiration Date July 15, 2025
Arrangement Duration 95 days
Aggregate Available 0
Dennis Mulroy [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On April 11, 2025, Dennis Mulroy, chief financial officer of the company, entered into a written plan for the potential sale of up to an aggregate 25,725 shares of common stock. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and is scheduled to terminate no later than December 31, 2025.
Name Dennis Mulroy
Title chief financial officer of the company
Rule 10b5-1 Arrangement Adopted true
Adoption Date April 11, 2025
Expiration Date December 31, 2025
Arrangement Duration 264 days
Aggregate Available 25,725
Eric Loumeau [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On April 11, 2025, Eric Loumeau, chief legal officer of the company, entered into a written plan for the potential sale of up to an aggregate 59,828 shares of common stock. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and is scheduled to terminate no later than May 20, 2026.
Name Eric Loumeau
Title chief legal officer of the company
Rule 10b5-1 Arrangement Adopted true
Adoption Date April 11, 2025
Expiration Date May 20, 2026
Arrangement Duration 404 days
Aggregate Available 59,828
Paul Lizzul [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On April 14, 2025, Paul Lizzul, chief medical officer of the company, entered into a written plan for the potential sale of up to an aggregate 36,500 shares of common stock. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and is scheduled to terminate no later than April 14, 2026.
Name Paul Lizzul
Title chief medical officer of the company
Rule 10b5-1 Arrangement Adopted true
Adoption Date April 14, 2025
Expiration Date April 14, 2026
Arrangement Duration 365 days
Aggregate Available 36,500